Zetia and Vancomycin hcl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zetia (ezetimibe) and Vancomycin hcl (vancomycin hydrochloride). Common drug interactions include deafness among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Zetia and Vancomycin hcl. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,113 Zetia users. Check the latest studies of Zetia.

What is Vancomycin hcl?

Vancomycin hcl has active ingredients of vancomycin hydrochloride. It is often used in clostridium difficile colitis. eHealthMe is studying from 6,530 Vancomycin hcl users. Check the latest studies of Vancomycin hcl.



On Jul, 08, 2026

29 people who take Zetia and Vancomycin hcl together, and have interactions are studied.

Zetia and Vancomycin hcl drug interactions.

What are the common drug interactions of Zetia and Vancomycin Hcl, by gender? *:

female:

  1. Deafness
  2. Drug hypersensitivity
  3. Hypersensitivity
  4. Surgery
  5. Dyspnoea (difficult or laboured respiration)
  6. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  7. Bacterial infection
  8. Skin lesion
  9. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  10. Tooth disorder (tooth disease)

male:

  1. Constipation
  2. Failure to thrive (inadequate weight gain and physical growth in children)
  3. Dyspnoea (difficult or laboured respiration)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Multiple injuries
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Oedema peripheral (superficial swelling)
  8. Pleural effusion (water on the lungs)
  9. Respiratory distress (difficulty in breathing)
  10. Surgery

What are the common drug interactions of Zetia and Vancomycin Hcl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Bacterial infection
  3. Blood pressure decreased
  4. Dyspnoea (difficult or laboured respiration)
  5. Pleural effusion (water on the lungs)
  6. Pulmonary congestion (congestion in the lungs)
  7. Respiratory rate increased (excess breathing rate/min)
  8. Skin lesion
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

  1. Drug hypersensitivity
  2. Emotional distress
  3. Epistaxis (bleed from the nose)
  4. Eye pain
  5. Face oedema (swelling of face)
  6. Fatigue (feeling of tiredness)
  7. Fibromyalgia (a long-term condition which causes pain all over the body)
  8. Gingival bleeding (bleeding gums)
  9. Gingival pain (gum pain)
  10. Gingivitis (inflammation of gums)

60+:

  1. Constipation
  2. Failure to thrive (inadequate weight gain and physical growth in children)
  3. Loss of consciousness
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Abdominal pain
  6. Arthralgia (joint pain)
  7. Balance disorder
  8. Bone pain
  9. Deformity (disfigurement)
  10. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 31.03%
  2. High Blood Pressure: 6 people, 20.69%
  3. Lung Cancer - Non-Small Cell (lung cancer): 5 people, 17.24%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 17.24%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 17.24%
  6. Cough: 5 people, 17.24%
  7. Pain: 2 people, 6.90%
  8. Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and Vancomycin hcl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zetia and Vancomycin hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zetia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin hcl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe and vancomycin hydrochloride (the active ingredients of Zetia and Vancomycin hcl, respectively), and Zetia and Vancomycin hcl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: